Form 4: Cryoport Director Linda Baddour Receives Significant Equity Grants

Cryoport, Inc. Director Linda Baddour was granted 23,214 restricted stock units and options to purchase 41,098 shares of common stock as part of her compensation.

Summary

• Cryoport, Inc. Director Linda Baddour reported an acquisition of 23,214 shares of common stock through a grant of restricted stock rights on June 6, 2025.
• These restricted stock rights vest in full on June 6, 2026, and will automatically convert to shares of common stock on a one-for-one basis upon vesting.
• Additionally, Ms. Baddour was granted options to buy 41,098 shares of common stock with an exercise price of $7 per share on June 6, 2025.
• These options will vest at a rate of 1/12th per month for twelve months, beginning July 6, 2025.
• The options have an expiration date of June 6, 2032.
• Following these transactions, Ms. Baddour beneficially owns 57,749 shares of common stock and 41,098 derivative securities (options).

Sentiment

Score: 7

Explanation: The sentiment is positive as it indicates standard compensation practices that align management/director interests with shareholders, without any negative implications or unusual transactions.

Positives

• The grant of restricted stock and options to Director Linda Baddour aligns her interests with those of the shareholders, incentivizing long-term company performance.
• Equity compensation is a common and effective way to retain experienced board members.

Future Outlook

The vesting schedules for the restricted stock and options indicate future increases in Director Baddour's direct ownership of Cryoport common stock, contingent on continued service and performance.

Management Comments

• "/s/ Linda Baddour" (Signature of Reporting Person)

Industry Context

Equity grants to directors are a standard practice across industries, particularly in publicly traded companies, to align the interests of board members with those of shareholders and to provide long-term incentives.

Corporate Governance

Related Party Transactions

• The transaction involves the grant of equity compensation to Linda Baddour, a director of Cryoport, Inc., which is a standard related-party transaction for director remuneration.

Stakeholder Impact

• Shareholders: The equity grants are intended to align the director's financial interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• Vesting of 23,214 restricted stock rights on June 6, 2026, converting to common stock.
• Monthly vesting of 41,098 options, starting July 6, 2025, over a twelve-month period.

Key Dates

Keywords

Cryoport, CYRX, Form 4, Insider Transaction, Equity Grant, Restricted Stock, Stock Options, Director Compensation, Beneficial Ownership